Scientific Advisory Board

ERX Pharmaceuticals’ scientific advisory board is comprised of an internationally-renowned group of advisors who are experts in the fields of obesity-related, and specifically leptin-related biology, pharmaceutical chemistry, and drug development strategy and execution.

business meeting in an office

Former SVP and Franchise Head for Diabetes and Obesity, Merck

Professor of Metabolic Research, Weill-Cornell Medical College, Vice-Chairman of the Board of the American Board of Obesity Medicine

Former SVP, Strategy & Medical & External Affairs, Bristol-Myers Squibb

Professor, Rockefeller University, Howard Hughes Medical Institute

Professor, Chair of Comparative Medicine, Professor of Neurobiology, Yale School of Medicine

Professor, Chairman of Japanese Diabetes Society, University of Tokyo, Japan

Chief Academic Officer and Senior Investigator, Joslin Diabetes Center, Professor of Medicine, Harvard Medical School

Assistant Professor, Harvard Medical School, Massachusetts General Hospital, Member of Broad Institute/MIT

Professor of Clinical Biochemistry & Medicine, University of Cambridge, U.K.

Former SVP and Franchise Head for Diabetes and Obesity, Merck

Professor, Chair of Division of Metabolic Diseases, Technische Universität München, Germany

Director of Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan